Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

HEART FAILURE DEVICES IMPROVE AND EXTEND LIVES1-5

HEART FAILURE AWARENESS DAYS 10-16 MAY 2021

#HeartFailureAwarenessDay

watch the
animation to
learn more

#

 

Heart failure is a serious medical condition where the heart muscle
is not able to pump enough blood to meet your body’s needs

to know more
about key facts
on heart failure,  the common 
signs & symptoms
and treatment options, Download THE infographic

DOWNLOAD HERE
#

which COMMON implantable cardiac devices
ARE used to help people with heart failure?

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDs)

Your protection against sudden cardiac arrest

visit the website
#

Cardiac Resynchronisation  Therapy  (CRT)

Your pacemaker for heart failure

visit the website

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDs)

Your protection against sudden cardiac arrest

visit the website
#
#

About Medtronic

Medtronic is a global leader in medical technology, employing more than 85,000 people worldwide. We serve physicians, hospitals and patients in nearly 160 countries. 

We have been helping cardiac patients for over 60 years.

We want to contribute to raising awareness about the importance of recognising heart failure, getting an accurate diagnosis and receiving optimal treatment.

FOR MORE INFORMATION

CTA

CTA

CTA

CTA

Information contained herein does not replace the recommendations of your healthcare professional (HCP). For further information, please contact your HCP.

References

1

Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. August 2006;27(16):1928-1932.Reverse full ref

2

Gold MR, Padhiar A, Mealing S, Sidhu MK, Tsintzos SI, Abraham WT. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study. JACC Heart Fail. September 2015;3(9):691-700.Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. January 20, 2005;352(3):225-237

3

HF Policy Network handbook (http://www.hfpolicynetwork.eu/handbook) 

4

Ponikowski P et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016 ; 37(27) : 2129-2200

5

Priori S et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J 2015 ; 36(41) : 2793-2867